Minerva Neurosciences
NERV
67 hedge funds and large institutions have $170M invested in Minerva Neurosciences in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 14 closing their positions.
11% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 19
0.7% more ownership
Funds ownership: 8.38% → 9.08% (+0.7%)
4% less funds holding
Funds holding: 70 → 67 (-3)
21% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 14
22% less capital invested
Capital invested by funds: $217M → $170M (-$46.7M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.67M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$1.38M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$930K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$403K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$336K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$6.08M |
| 2 |
NC
Nexthera Capital
New York
|
-$4.08M |
| 3 |
JGC
J. Goldman & Co
New York
|
-$1.19M |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$950K |
| 5 |
Renaissance Technologies
New York
|
-$858K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EMG
76
Ellington Management Group
Old Greenwich,
Connecticut
| – | -$106K | -1,738 | Closed |
|
|
SCA
77
Secor Capital Advisors
New York
| – | -$89K | -1,456 | Closed |
|
78
William Blair & Company
Chicago,
Illinois
| – | -$76K | -1,250 | Closed |
|
79
UBS Group
Zurich,
Switzerland
| – | -$48K | -785 | Closed |
|
80
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$13.6K | -275 | -96% |
|
81
Simplex Trading
Chicago,
Illinois
| – | -$3K | -50 | Closed |
|
NERV Hedge Fund Activity: Q4 2017 in Review
67 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q4 2017, worth a combined $170M — down 22% from $217M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of NERV and 11 opened new positions — a net loss of 3 holders — while 19 trimmed existing stakes and 21 added.
The largest buyer was JP Morgan Chase, adding an estimated $1.67M. The largest seller was Fidelity Investments, cutting an estimated $6.08M.
- 67 institutional investors held Minerva Neurosciences (NERV) as of Q4 2017, down from 70 in Q3 2017.
- Funds reported $170M of Minerva Neurosciences stock for Q4 2017, down 22% quarter-over-quarter.
- 11 funds opened new Minerva Neurosciences positions in Q4 2017 and 14 closed out, a net change of -3 holders.
- The largest Minerva Neurosciences buyer in Q4 2017 was JP Morgan Chase, an estimated $1.67M added.
- The largest Minerva Neurosciences seller in Q4 2017 was Fidelity Investments, an estimated $6.08M sold.
Based on aggregated 13F filings for Q4 2017.